올릭스

226950KOSDAQView the 바이오 R&D sectorTheme Bio & healthcare

97,600KRWMarket close of 10/20 (Tue)

Down -4.03%-4,100KRWMarket close of 10/20 (Tue)

Preliminary value right after the close — replaced by official KRX data tomorrow morningClose of 10/21 (Wed)106,900KRWUp +9.53%

Preliminary · just after the close · replaced by official KRX data tomorrow morning

Open
99,600
High
102,400
Low
93,300
Day range
Day range low 93,300 high 102,400, open 99,600, close 97,600, previous close 101,700
Volume
20×10K shares
19.1B KRW 0.71× the 20-session average

Market close of 10/20 (Tue)

Where it sits in the 1-year range

1-year close range 87,300 to 207,000 won, 9% up from the low

9% of the way up from the lowest close in 1 year (252 sessions) · -52.9% from the high

Something to check

1 to check: operating loss

Free · no sign-inSource from 2021-05-17

Points to check

  • Earningsto check-41.6B KRWOperating income over the last four quarters -41.6B KRW (loss)Operating income, 8 quarters
  • Daily moveusual range-4.03%-4.03%, 0.9× the usual (20-session average ±4.67%)
    That day -4.03% · usual ±4.67% · large-move threshold ±9.3%
  • Trading valueusual range0.7×19.1B KRW, 0.7× the 20-session average
    0.71× the 20-session average · check threshold 3×

The other 3 are within the usual range

  • Recent filings0Last 14 days
  • Foreign & institutional+2.3B KRWusual range
  • Data date10/20 (Tue)Market close
See the full check report

Same sector · 바이오 R&D

Down -2.19%

· 16 of 64 stocks up, preferred shares excluded · trading value 190.5B KRW

Same sector · top by trading value
Stock20DChangeTrading value
알테오젠Close over the last 20 sessions -9.6%Down -3.35%51.1B KRW
디앤디파마텍Close over the last 20 sessions -11.8%Down -1.93%15.1B KRW
리가켐바이오Close over the last 20 sessions -15.4%Down -1.41%12.1B KRW
프로티나Close over the last 20 sessions +31.8%Up +7.38%10.0B KRW
바이오인프라Close over the last 20 sessions +123.3%Down -6.80%9.3B KRW

Schedule

  • Q3 report due · 11/16 (Mon) · in 26 days
  • Next data 10/22 (Thu) after 08:50

For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.